Other
Estimated litigation liability
Year-over-year, this metric declined by 100.0%, from $220.00M to $0.00. Over 2 years (FY 2021 to FY 2025), Estimated litigation liability shows a downward trend with a -100.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ1 2026May 7, 2026
Metric ID:
other_litigation_reserveHistorical Data
12 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.25B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $242.00M | $220.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — | — | — | — | — | -9.1% | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | — | -100.0% | -100.0% |
Range$0.00 – $1.25B
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Current Streak2+ quarters decline
Estimated litigation liability at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's estimated litigation liability?
- Gilead Sciences (GILD) reported estimated litigation liability of $0.00 in Q1 2026.
- How has Gilead Sciences's estimated litigation liability changed year-over-year?
- Gilead Sciences's estimated litigation liability decreased by 100.0% year-over-year, from $220.00M to $0.00.
- What is the long-term trend for Gilead Sciences's estimated litigation liability?
- Over 2 years (2021 to 2025), Gilead Sciences's estimated litigation liability has grown at a -100.0% compound annual growth rate (CAGR), from $1.25B to $0.00.